Page last updated: 2024-10-16

adenine and Hyperplasia

adenine has been researched along with Hyperplasia in 9 studies

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research Excerpts

ExcerptRelevanceReference
"Nodular regenerative hyperplasia (NRH) leading to non-cirrhotic portal hypertension has been described in HIV-infected patients and has been linked to didanosine."3.77The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. ( Bénet, T; Billioud, C; Boibieux, A; Brochier, C; Chevallier, M; Cotte, L; Ferry, T; Miailhes, P; Scoazec, JY; Vanhems, P; Zoulim, F, 2011)
" Louis, MO) on vascular calcification in a rodent model of progressive uremia with accompanying secondary hyperparathyroidism induced by dietary adenine."3.75The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. ( Cattley, R; Davis, J; Henley, C; Lane, N; Li, X; Martin, D; Miller, G; Shalhoub, V; Shatzen, E; Yao, W, 2009)
"Adenine-treated rats showed marked elevations of serum phosphorus, PTH and FGF23 levels associated with parathyroid hyperplasia and aortic calcification."1.33[Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. ( Abe, M; Kobayashi, N; Miyata, S; Nagano, N; Wada, M; Wakita, S, 2005)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Sato, H3
Goto, M3
Nishimura, G3
Morimoto, N3
Tokushima, H3
Horii, Y3
Takahashi, N3
Du, J1
Liang, L1
Liu, S1
Yang, X1
Cao, S1
Zhang, H1
Su, H1
Gong, X1
Chen, Q1
Kong, X1
Xu, D1
Schulz, S1
Reichert, S1
Streetz, K1
Trautwein, C1
Reichert, Y1
Gläser, C1
Schaller, HG1
Stein, JM1
Henley, C1
Davis, J1
Miller, G1
Shatzen, E1
Cattley, R1
Li, X1
Martin, D1
Yao, W1
Lane, N1
Shalhoub, V1
Cotte, L1
Bénet, T1
Billioud, C1
Miailhes, P1
Scoazec, JY1
Ferry, T1
Brochier, C1
Boibieux, A1
Vanhems, P1
Chevallier, M1
Zoulim, F1
Nagano, N1
Miyata, S1
Abe, M1
Wakita, S1
Kobayashi, N1
Wada, M1
Tsuda, H1
Matsumoto, K1
Iwase, T1
Nishida, Y1
Baba, H1
Dubey, RK1
Gillespie, DG1
Shue, H1
Jackson, EK1
Kasprzak, A1
Rebuffat, P1
Warchol, JB1
Mazzocchi, G1
Nussdorfer, GG1
Malendowicz, LK1

Other Studies

9 other studies available for adenine and Hyperplasia

ArticleYear
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Neointimal hyperplasia in the inferior vena cava of adenine-induced chronic kidney disease rats with aortocaval fistulas.
    Clinical and experimental nephrology, 2020, Volume: 24, Issue:11

    Topics: Adenine; Animals; Aorta; Arteriovenous Shunt, Surgical; Blood Urea Nitrogen; Constriction, Pathologi

2020
Tumor necrosis factor-α and oral inflammation in patients with Crohn disease.
    Journal of periodontology, 2014, Volume: 85, Issue:10

    Topics: Adenine; Adult; Age Factors; Alleles; Case-Control Studies; Crohn Disease; Female; Genetic Variation

2014
The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.
    European journal of pharmacology, 2009, Aug-15, Volume: 616, Issue:1-3

    Topics: Adenine; Animals; Biomimetic Materials; Biphenyl Compounds; Bone and Bones; Calcinosis; Calcium; Cin

2009
The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
    Journal of hepatology, 2011, Volume: 54, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Didano

2011
[Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Clinical calcium, 2005, Volume: 15 Suppl 1

    Topics: Adenine; Animals; Aortic Diseases; Calcinosis; Calcium; Disease Models, Animal; Drug Administration

2005
Enhanced neoplastic lesion development with adenine-induced experimental multicystic nephropathy by adenine--a model system for the analysis of renal tumor generation in long-term hemodialysis patients.
    Cancer letters, 1994, Aug-15, Volume: 83, Issue:1-2

    Topics: Adenine; Adenoma; Animals; Diethylnitrosamine; Epithelium; Hyperplasia; Kidney Diseases; Kidney Neop

1994
A(2B) receptors mediate antimitogenesis in vascular smooth muscle cells.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: 2-Chloroadenosine; Adenine; Adenosine; Adenosine Kinase; Adenosine-5'-(N-ethylcarboxamide); Animals;

2000
Effects of the hypocholesterolemic drug, 4-aminopyrazolo (3,4-d) pyrimidine (4-APP), on the hamster adrenal cortex. An ultrastructural and functional study.
    Virchows Archiv. B, Cell pathology including molecular pathology, 1991, Volume: 60, Issue:4

    Topics: Adenine; Adrenal Glands; Animals; Cricetinae; Depression, Chemical; Dexamethasone; Female; Hydrocort

1991